Crimean-Congo Hemorrhagic Fever and Autoimmunity: A Georgian Viewpoint Improved by Awareness Survey
Keywords:
Georgia, student awareness, infectious diseases, Crimean-Congo hemorrhagic fever, CCHF.Abstract
BACKGROUND: Crimean Congo hemorrhagic fever (CCHF) is primarily transmitted through the Hyalomma tick a virus found in the Bunyaviridae family. The disease spreads when an individual is bitten by a tick or comes into contact, with one directly. Additionally consuming milk or being exposed to contaminated animal tissues or blood can lead to transmission. While human-to-human transmission can occur through contact with blood or bodily fluids such cases are mostly observed in settings. Around one out of every five individuals infected with the virus shows signs of illness whereas animals and ticks do not exhibit any symptoms of infection. People infected with CCHF typically experience a specific fever at the onset, which may progress rapidly into a hemorrhagic syndrome causing organ failure and potentially leading to death in severe instances. Georgia, located in the South Caucasus region shares borders with countries where CCHF transmission is prevalent. Given that, nearly half of Georgia's population engages in agriculture and resides in areas where they may be at risk, of contracting CCHF. In 2009 the National Electronic Integrated Disease Surveillance System (EIDSS) was introduced to monitor cases in Georgia. Physicians, in healthcare facilities in Georgia suspect a patient may have CCHF and report it to the Georgian National Centre for Disease Control and Public Health through EIDSS, a part of the surveillance system for reporting diseases.
METHODS: To study, CCHF information was collected from news media and health publications between 2014 and 2023. Additionally, a cross-sectional survey was conducted to assess peoples’ understanding of CCHF and autoimmunity. The survey consisted of twenty multiple-choice questions covering transmission, symptoms, prevention, and basic autoimmune concepts. The sample of 500 participants ensured representation. Descriptive statistics were utilized to analyze the data for awareness levels and common beliefs.
RESULTS: Insights from survey responses collected from individuals in Georgia unveiled intriguing aspects of their awareness and attitudes toward autoimmunity and CCHF. While most participants (60%) were familiar with CCHF it was concerning that 40% could accurately identify the disease transmission methods. Furthermore, the survey indicated that 70% of students expressed worries regarding autoimmunity. However, there seems to be a gap between awareness and understanding of conditions as half of respondents admitted knowing, about them. The difference, in outcomes, demonstrates the impact of campaigns and awareness programs in enhancing students understanding and correcting misconceptions. It underscores the importance of public health strategies that focus on educating people about disorders alongside managing infectious diseases like CCHF. Collaboration among health authorities, schools, and community groups is crucial for bridging knowledge gaps and promoting understanding among students.
CONCLUSION: The comprehensive examination of CCHF, in Georgia, enhanced by a study involving adults offers perspectives on existing awareness levels and misunderstandings. Closing these knowledge disparities through focused public health efforts and educational programs is crucial, for empowering individuals to safeguard themselves and their communities from autoimmune conditions.
References
Greiner AL, Mamuchishvili N, Kakutia N, Stauffer K, Geleishvili M, Chitadze N, et al. Crimean-Congo Hemorrhagic Fever Knowledge, Attitudes, Practices, Risk Factors, and Seroprevalence in Rural Georgian Villages with Known Transmission in 2014. PLoS One. 2016 Jun 23;11(6). doi: 10.1371/journal.pone.0158049.
Georgian health authorities confirm first 2023 cases of Crimean–Congo hemorrhagic fever. [Internet]. Available from: https://agenda.ge/en/news/2023/2023#gsc.tab=0
Tbilisi, Georgia: Three people being treated for Crimean-Congo hemorrhagic fever - Outbreak News Today. Outbreak News Today. 2022 Apr 30. Available from: https://outbreaknewstoday.com/tbilisi-georgia-three-people-being-treated-for-crimean-congo-hemorrhagic-fever-26445/
Three women die from Crimean–Congo hemorrhagic fever in Georgia. [Internet]. Available from: https://agenda.ge/en/news/2014/1924#gsc.tab=0
Georgia reports 42 cases of Crimean-Congo virus this year, an upward trend. [Internet]. Available from: https://frontnews.ge/en/news/details/28755
Greiner AL, Mamuchishvili N, Salyer SJ, Stauffer K, Geleishvili M, Zakhashvili K, et al. Increase in Reported Crimean-Congo Hemorrhagic Fever Cases — Country of Georgia, 2014. Centers for Disease Control and Prevention. 2015 Mar 6. Available from: https://stacks.cdc.gov/view/cdc/53180
Prine J. College of Pharmacy, CDC develop vaccine for virus. UGA Today. 2019 Jul 1. Available from: https://news.uga.edu/college-of-pharmacy-cdc-develop-vaccine-for-virus/
Karaaslan E, Çetin NS, Kalkan-Yazıcı M, Hasanoğlu S, Karakeçili F, Özdarendeli A, et al. Immune responses in multiple hosts to Nucleocapsid Protein (NP) of Crimean-Congo Hemorrhagic Fever Virus (CCHFV). PLoS Negl Trop Dis. 2021 Dec 1;15(12). doi: 10.1371/journal.pntd.0009973.
Downloads
Published
How to Cite
License
Copyright (c) 2024 Aruna Rajeswari BB
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org